You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR SENSORCAINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SENSORCAINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00915473 ↗ Greater Occipital Nerve Block for Migraine Prophylaxis Completed National Center for Advancing Translational Science (NCATS) Phase 4 2009-06-01 Migraine is a common neurological condition that can be disabling, particularly if chronic. Greater occipital nerve (GON) block has been utilized for decades for the treatment of migraine in the absence of a single randomized, placebo-controlled trial documenting its effectiveness. Hypothesis: Greater occipital nerve block reduces the frequency of days with moderate or severe headache in patients with episodic or chronic migraine.
NCT00915473 ↗ Greater Occipital Nerve Block for Migraine Prophylaxis Completed Mayo Clinic Phase 4 2009-06-01 Migraine is a common neurological condition that can be disabling, particularly if chronic. Greater occipital nerve (GON) block has been utilized for decades for the treatment of migraine in the absence of a single randomized, placebo-controlled trial documenting its effectiveness. Hypothesis: Greater occipital nerve block reduces the frequency of days with moderate or severe headache in patients with episodic or chronic migraine.
NCT01073995 ↗ The Effectiveness of Selective Nerve Root Injections in Preventing the Need for Surgery Completed Horizon Health Network Phase 3 2010-03-01 The median Orthopaedic surgery wait time in Canada is 36.7 weeks (Esmail 2008), thus there is a need to find alternative treatments for pathologies such as lumbar disc herniations (LDH). The literature has demonstrated that selective nerve root injections (SNRI) are able to alleviate sciatic symptoms caused by LDH (Riew 2006) and may be beneficial as an alternative to surgery. It is necessary to determine whether SNRIs provide significant symptom resolution alleviating the need for surgery, or to determine if their success is transient and delays the time to surgery. The purpose of the proposed study is to evaluate the success of SNRI in patients suffering with LDH and to determine which factors influence outcome. Over the span of 2 years, data from 100 patients will be collected. These patients will be surgical candidates and have exhausted all non-operative measures prior to receiving a SNRI. Upon first assessment, each eligible patient will be randomly assigned to the treatment (steroid) or control (saline) group. The patient and all treating physicians will be blinded to the treatment given. Each patient will be followed over their course of treatment and information pertaining to their pain and symptoms will be recorded using standard questionnaires. Patient demographics, diagnosis, Worker's Compensation status, spinal levels treatment/outcome, and time from referral to treatment will also be evaluated. The primary outcome measure will be defined as the avoidance of surgery.
NCT01615939 ↗ A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block Terminated Northwestern University Phase 4 2012-06-01 The purpose of this study is to compare the incidence of postoperative symptoms of neurologic injury after a single shot infragluteal-parabiceps sciatic nerve block versus a continuous infragluteal-parabiceps sciatic nerve catheter.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SENSORCAINE

Condition Name

Condition Name for SENSORCAINE
Intervention Trials
Breast Cancer 2
Pain 2
Pain, Postoperative 2
Headache 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SENSORCAINE
Intervention Trials
Pain, Postoperative 5
Fractures, Bone 3
Headache 3
Femoracetabular Impingement 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SENSORCAINE

Trials by Country

Trials by Country for SENSORCAINE
Location Trials
United States 17
India 1
Hong Kong 1
Canada 1
Denmark 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SENSORCAINE
Location Trials
Illinois 4
Minnesota 3
California 2
Massachusetts 2
Maine 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SENSORCAINE

Clinical Trial Phase

Clinical Trial Phase for SENSORCAINE
Clinical Trial Phase Trials
Phase 4 10
Phase 3 5
Phase 2 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SENSORCAINE
Clinical Trial Phase Trials
Completed 16
Terminated 5
Withdrawn 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SENSORCAINE

Sponsor Name

Sponsor Name for SENSORCAINE
Sponsor Trials
Northwestern University 3
Mayo Clinic 3
Postgraduate Institute of Medical Education and Research, Chandigarh 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SENSORCAINE
Sponsor Trials
Other 26
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.